2025
Effect of peri‐operative pharmacological interventions on postoperative delirium in patients having cardiac surgery: a systematic review and Bayesian network meta‐analysis
Queiroz I, Barbosa L, Ruelas M, Araújo B, Defante M, Tavares A, de Mesquita C, Pimentel T, Mendes B, Felix I, Rivera A, Ferreira R, de Oliveira H, Righetto B, Smischney N, Tong G, Ma D. Effect of peri‐operative pharmacological interventions on postoperative delirium in patients having cardiac surgery: a systematic review and Bayesian network meta‐analysis. Anaesthesia 2025 PMID: 40888048, DOI: 10.1111/anae.16757.Peer-Reviewed Original ResearchIncidence of postoperative deliriumRandomised controlled trialsCardiac surgeryPostoperative deliriumPharmacological interventionsControlled TrialsRisk ratioMeta-analysis of randomised controlled trialsNetwork meta-analysis of randomised controlled trialsBayesian Network Meta-AnalysisEffective pharmacological strategiesGrading of RecommendationsIntensive care unitEffects of pharmacological interventionsCertainty of evidenceCumulative ranking curveEffective prevention strategiesNetwork Meta-AnalysisEffective interventionsPharmacological strategiesCare unitPrevention strategiesSystematic reviewLow certaintyPatients
2022
The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials
Cho K, Park S, Koyanagi A, Jacob L, Yon D, Lee S, Kim M, Kim S, Kim B, Shin J, Smith L. The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta‐analyses of randomized controlled trials. Obesity Reviews 2022, 23: e13464. PMID: 35582982, DOI: 10.1111/obr.13464.Peer-Reviewed Original ResearchConceptsMeta-analyses of randomized controlled trialsLifestyle modificationRandomized Controlled TrialsMeta-analysesUmbrella reviewUmbrella review of meta-analyses of randomized controlled trialsReview of meta-analyses of randomized controlled trialsEffects of pharmacological interventionsControlled TrialsEvaluating meta-analysesNonalcoholic fatty liver diseaseStrength of evidenceStandardized mean differencePharmacological interventionsRandom-effects modelAMSTAR-2Treat NAFLD patientsInactive controlLiver diseaseFatty liver diseaseEffects of pharmacological treatmentEffect sizeLifestyleCochrane LibraryMean difference
2014
Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor
Haley K, Russell T, Boshkov L, Leger R, Garratty G, Recht M, Nazemi K. Fatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor. Journal Of Blood Medicine 2014, 5: 55-58. PMID: 24868179, PMCID: PMC4031206, DOI: 10.2147/jbm.s59192.Peer-Reviewed Original ResearchDrug-induced immune hemolytic anemiaImmune hemolytic anemiaHemolytic anemiaTreating many pediatric cancersSide effects of pharmacological interventionsEvidence of complement activationUncommon side effectMulti-organ failureRed cell antibodiesEffects of pharmacological interventionsPediatric patientsCell antibodiesAcute onsetAffected patientsEffective therapyEarly recognitionPediatric cancerBrain tumorsPharmacological interventionsComplement activationAnemiaPatientsCarboplatinPlasmapheresisTumor
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply